TCF7L2 rs4905166: Understanding Your Genetic Variant
The rs4905166 variant is a single nucleotide polymorphism located within the TCF7L2 gene, a region widely recognized for its influence on glucose metabolism. Research indicates that variations in this locus are associated with altered insulin secretion and susceptibility to type 2 diabetes.
What each genotype means
Typical glucose regulation
You carry two copies of the common G allele at rs4905166 in the TCF7L2 locus. Research indicates that this genotype reflects the baseline population profile for glucose homeostasis and is not associated with elevated genetic susceptibility to type 2 diabetes. However, complex traits like metabolic regulation are governed by many lifestyle factors and genetic markers throughout the genome.
Found in approximately 50% to 55% of individuals of European ancestry and is the predominant genotype across most global populations.
Modestly altered glucose susceptibility
You carry one copy of the A minor allele and one copy of the G allele at rs4905166. While the broader TCF7L2 locus is strongly tied to pancreatic beta-cell function and insulin secretion, direct clinical evidence specifically isolated to rs4905166 remains limited and largely reflects linkage with other known regional variants. Carrying this genotype may confer a subtle statistical difference in metabolic trait profiles, but it does not diagnose any condition.
Carried by approximately 40% of individuals of European ancestry, with lower frequencies observed in East Asian populations.
Altered glucose susceptibility
You carry two copies of the A minor allele at rs4905166 within the TCF7L2 gene region. In population-level research, variations across the TCF7L2 locus have been correlated with altered glucose regulation and type 2 diabetes susceptibility, although direct independent functional evidence for this specific variant remains limited. This statistical association does not predict disease onset, and routine metabolic health practices remain the primary drivers of individual outcomes.
Observed in roughly 7% to 8% of individuals of European ancestry and is relatively uncommon worldwide.
What is rs4905166?
The rs4905166 variant is a specific change in the DNA sequence located within the TCF7L2 (Transcription Factor 7-Like 2) gene. In genomics, a single nucleotide polymorphism (SNP) like rs4905166 represents a position where one building block of DNA—a nucleotide—differs between individuals. This variant sits in a non-coding region of the gene, meaning it does not directly change the protein structure itself, but rather influences how the gene is regulated or expressed. Because TCF7L2 is a critical player in the Wnt signaling pathway, which is essential for cell development and metabolic function, researchers study these variants to understand how subtle genetic differences can influence physiological processes. By mapping these variations, scientists aim to clarify the complex genetic architecture that contributes to metabolic health and the regulation of blood sugar levels across diverse human populations.
The Role of the TCF7L2 Gene
The TCF7L2 gene provides instructions for making a protein that acts as a transcription factor. Transcription factors are proteins that bind to specific regions of DNA to help control the activity of other genes. TCF7L2 is particularly important in the pancreas, where it plays a vital role in the function of beta-cells. Beta-cells are responsible for producing and secreting insulin, the hormone that regulates blood glucose levels. When TCF7L2 function is altered, it can impact the efficiency of proinsulin processing and the body's overall insulin response to glucose. Because of its central role in pancreatic health, the TCF7L2 locus has been identified as one of the most significant genetic markers for type 2 diabetes risk. Understanding how this gene operates helps researchers piece together the biological mechanisms that lead to impaired glucose regulation and the development of metabolic conditions.
Research and Evidence Strength
The association between the TCF7L2 locus and type 2 diabetes is one of the most robustly replicated findings in human genetics. Numerous studies have confirmed that variants in this gene are linked to impaired insulin secretion and higher fasting proinsulin levels. While the TCF7L2 locus as a whole is considered a potent risk factor, the evidence for specific individual SNPs like rs4905166 can vary in strength depending on the population studied. Much of the existing research focuses on the broader TCF7L2 region, which has been consistently associated with diabetes risk across European, East Asian, and other ancestral groups. It is important to note that while these statistical associations are strong, they represent risk factors rather than deterministic causes. Genetic predisposition is only one piece of the puzzle, as environmental factors, lifestyle, and other genetic variants also play significant roles in determining an individual's metabolic health outcomes.
What You Can and Cannot Do
Information about your genotype for rs4905166 is for educational purposes and should not be used for medical diagnosis or to predict personal health outcomes. Genetic variants are statistical markers, not medical tests; they do not account for the complex interplay of diet, physical activity, and other health factors that influence glucose regulation. If you are concerned about your blood sugar levels, diabetes risk, or metabolic health, the most effective approach is to consult with a healthcare professional. They can provide appropriate screenings, such as A1C or fasting glucose tests, and offer personalized guidance based on your clinical history. Never use genetic information to make decisions about medication or lifestyle changes without first discussing them with your doctor or a qualified pharmacist. Genetic data provides a window into your biological predispositions, but it is not a substitute for professional medical evaluation and evidence-based clinical care.
How common is this variant?
The minor allele frequency for variants in the TCF7L2 locus is approximately 0.28 in European ancestral populations, though frequencies can vary significantly across different global ancestries.
Frequently asked questions
Does having a TCF7L2 variant mean I will get diabetes?
No. Genetic variants in TCF7L2 are associated with an increased statistical risk, but they do not guarantee the development of diabetes. Many people with these variants never develop the condition, as it is influenced by a combination of genetics, lifestyle, and environment.
Should I get tested for TCF7L2 variants?
Routine genetic testing for TCF7L2 is not currently recommended for clinical diagnosis. Standard medical screenings, such as blood glucose and A1C tests, are the established methods for assessing your current metabolic health.
Can I change my risk if I have this variant?
While you cannot change your DNA, you can manage your metabolic health through lifestyle choices. Maintaining a balanced diet, regular physical activity, and routine medical check-ups are effective ways to support healthy blood sugar levels regardless of your genetic background.
Where can I find more information on TCF7L2?
You can find reliable information through resources like MedlinePlus Genetics or the GWAS Catalog. These databases provide summaries of current research and the known associations between specific genes and health traits.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4905166?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 strongly associated with type 2 diabetes risk and modulation of glycemic response to dietary fiber.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.
This variant is one of the strongest genetic risk factors for Type 2 diabetes, affecting insulin secretion.